Perrigo Stock Forecast, Price & News

Perrigo's stock was trading at $46.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PRGO shares have decreased by 2.3% and is now trading at $44.99.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Perrigo.

Perrigo is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Perrigo.

Perrigo Company PLC (NYSE:PRGO) posted its earnings results on Wednesday, August, 5th. The company reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.16. The company earned $1.22 billion during the quarter, compared to the consensus estimate of $1.23 billion. Perrigo had a return on equity of 10.05% and a net margin of 4.73%. The business's quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.86 EPS.
View Perrigo's earnings history.

Perrigo declared a quarterly dividend on Wednesday, July 29th. Stockholders of record on Friday, August 28th will be given a dividend of $0.225 per share on Tuesday, September 15th. This represents a $0.90 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date of this dividend is Thursday, August 27th.
View Perrigo's dividend history.

Perrigo updated its FY20 earnings guidance on Thursday, September, 17th. The company provided earnings per share guidance of $3.95-4.15 for the period, compared to the Thomson Reuters consensus estimate of $4.02.

8 analysts have issued 1 year price objectives for Perrigo's shares. Their forecasts range from $53.00 to $70.00. On average, they anticipate Perrigo's share price to reach $58.43 in the next twelve months. This suggests a possible upside of 29.9% from the stock's current price.
View analysts' price targets for Perrigo.

Perrigo saw a increase in short interest in the month of August. As of August 14th, there was short interest totaling 4,340,000 shares, an increase of 11.3% from the July 30th total of 3,900,000 shares. Based on an average daily trading volume, of 848,400 shares, the short-interest ratio is presently 5.1 days.
View Perrigo's Short Interest.

Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Mylan (MYL), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Supernus Pharmaceuticals (SUPN).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.74%), London Co. of Virginia (2.02%), Sound Shore Management Inc CT (1.75%), Nuveen Asset Management LLC (1.54%), Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.51%) and Bank of New York Mellon Corp (0.72%). Company insiders that own Perrigo stock include Geoffrey M Parker, Grainne Quinn, Murray S Kessler, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II and Todd W Kingma.
View institutional ownership trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Alyeska Investment Group L.P., FMR LLC, Diamond Hill Capital Management Inc., Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, Balyasny Asset Management LLC, Vanguard Group Inc., and Neuberger Berman Group LLC. Company insiders that have sold Perrigo company stock in the last year include Grainne Quinn, Ronald Craig Janish, and Todd W Kingma.
View insider buying and selling activity for Perrigo.

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, London Co. of Virginia, Harel Insurance Investments & Financial Services Ltd., UBS Group AG, Phoenix Holdings Ltd., State of Wisconsin Investment Board, AQR Capital Management LLC, and Assenagon Asset Management S.A.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Murray S Kessler, Svend Andersen, Theodore R Samuels II, and Todd W Kingma.
View insider buying and selling activity for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $44.99.

Perrigo has a market capitalization of $6.14 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,200 workers across the globe.

The official website for Perrigo is www.perrigo.com.

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]